Tonix Pharmaceuticals Holding (TNXP) EPS (Basic) (2014 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted EPS (Basic) of -$2.44 for Q2 2026, up 16.87% on a QoQ basis from -$2.93 in Q1 2026, and up 36.82% year-over-year from -$1.78 in Q2 2025.
Powered by 
Analysis
Tonix Pharmaceuticals Holding (TNXP) EPS (Basic) (2014 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding has reported EPS (Basic) for 13 years, with the latest figure at -$2.44 in Q2 2026.
- On a quarterly basis, EPS (Basic) rose 36.82% year-over-year to -$2.44 in Q2 2026; TTM through Jun 2026 was -$9.6, a 13.63% increase from a year earlier, with the FY2025 full-year figure at -$14.57, up 91.75% from the prior year.
- EPS (Basic) was -$2.44 for Q2 2026 at Tonix Pharmaceuticals Holding, up from -$2.93 in the prior quarter.
- The five-year high for EPS (Basic) was -$2.44 in Q2 2026, with the low at -$32137.5 in Q1 2022.
- Average EPS (Basic) over 5 years is -$6780.3, with a median of -$1259.7 recorded in 2024.
- The sharpest annual moves came in 2022 and 2025: EPS (Basic) plunged 2157.08% in 2022, then jumped 99.8% in 2025.
- Over 5 years, EPS (Basic) stood at -$19073.3 in 2022, then jumped by 73.1% to -$5130.9 in 2023, then surged by 99.41% to -$30.02 in 2024, then soared by 81.64% to -$5.51 in 2025, then surged by 55.77% to -$2.44 in 2026.
- The last three EPS (Basic) figures came in at -$2.44 (Q2 2026), -$2.93 (Q1 2026), and -$5.51 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 2.30 |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 1.68 |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -0.04 |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 0.33 |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | -3.06 |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 2.12 |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 2.92 |
| 10 | Tonix Pharmaceuticals Holding | 220.65 Mn | 220.65 Mn | 12.84 Mn | -2.44 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.44 |
| Mar 31, 2026 | -2.93 |
| Dec 31, 2025 | -5.51 |
| Sep 30, 2025 | -3.59 |
| Jun 30, 2025 | -3.86 |
| Mar 31, 2025 | -2.84 |
| Dec 31, 2024 | -30.02 |
| Sep 30, 2024 | -22.88 |
| Jun 30, 2024 | -1,928.37 |
| Mar 31, 2024 | -591.06 |
| Dec 31, 2023 | -5,130.89 |
| Sep 30, 2023 | -5,840.29 |
| Jun 30, 2023 | -8,571.95 |
| Mar 31, 2023 | -10,418.24 |
| Dec 31, 2022 | -19,073.31 |
| Sep 30, 2022 | -13,820.22 |
| Jun 30, 2022 | -24,459.82 |
| Mar 31, 2022 | -32,137.47 |
| Dec 31, 2021 | -51,938.49 |
| Sep 30, 2021 | -32,000.00 |